Faricimab (Vabysmo)

faricimab · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Faricimab (Vabysmo), covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Intravitreal Faricimab in Patients With Refractory Macular Edema [Phase 2]